CARY, N.C. (8 February 2017) – Arysta LifeScience recently announced that it has entered into a global collaboration with DuPont Crop Protection for the development of new foliar insecticides based on the market-leading product, DuPont™ Rynaxypyr® (chlorantraniliprole). The long-term agreement between the two companies allows Arysta LifeScience to combine Rynaxypyr® insect control in premixes with acetamiprid, thereby creating novel insecticidal formulations that more efficiently and conveniently address needs of growers.
“Through our collaboration with DuPont, we are expanding our development of proprietary foliar insecticides for specialty crop protection,” said Diego Lopez Casanello, president, Arysta LifeScience. “The premix formulations will control a broader spectrum of pests than straight Rynaxypyr® products, which will increase its utility to growers in many countries around the world.”
“Our agreement with Arysta LifeScience increases the value of our investment in Rynaxypyr®, and most importantly, gives growers more tools to effectively manage insects,” said Timothy P. Glenn, president, DuPont Crop Protection.
Combining Rynaxypyr® with acetamiprid offers multiple benefits including:
About Arysta LifeScience
Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 4,000 employees working in over 100 countries to serve customers worldwide, had 2015 revenues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products Corporation (NYSE:PAH), a global innovator of technologically advanced specialty chemical products and provider of technical services (www.platformspecialtyproducts.com). For more information on Arysta LifeScience, visit www.arystalifescience.com.
Media Contact: Carey Dorman Director – Corporate Development Platform Specialty Products Corporation 1-561-406-8465